Heilongjiang Zbd Pharmaceutical Co.,Ltd.’s Net Profit Rose 1.2% in First Quarter of 2022

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (黑龙江珍宝岛药业股份有限公司) (603567.SH) reported a net profit of 157.9 million yuan in the first quarter of 2022, up 1.2% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 38.2% year-on-year.

At the end of the reporting period, it had 11.8 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 38.8%.